---
$id: https://graph.org.ai/products/commodity/51142508
$type: Product
source: UNSPSC
code: "51142508"
title: "Pramipexole"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pramipexole

**UNSPSC Code**: 51142508
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 83619PEU5T. European Medicines Agency schedules Pramipexole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09990MIG. Pramipexole generally arises in the molecular formula C10H17N3S. The term PRAMIPEXOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) PRAMIPEXOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pramipexole under HS 29341000 and SITC 51579. As of Q4 2014, PRAMIPEXOLE remains the US FDA Preferred Term for this commodity. Pramipexole bears US NLM identifiers UMLS ID C0074710 and NCI Concept Code C66456. SMILES: CCCNC1CCC2=C(C1)SC(=N2)N.

